The Zhitong Finance App learned that according to the Hong Kong Stock Exchange's disclosure on August 28, Hangzhou Tangji Medical Technology Co., Ltd. (abbreviation: Tangji Medical) submitted a listing application to the main board of the Hong Kong Stock Exchange, with ICBC International and Caitong International as co-sponsors. As of the last practical date, the company's core product GBS has received regulatory approval in 11 other countries and regions, including Hong Kong, Indonesia, Thailand, Vietnam, Saudi Arabia, Malaysia, Ecuador, Colombia, the Philippines, Singapore and Brazil.

The Zhitong Finance App learned that according to the Hong Kong Stock Exchange's disclosure on August 28, Hangzhou Tangji Medical Technology Co., Ltd. (abbreviation: Tangji Medical) submitted a listing application to the main board of the Hong Kong Stock Exchange, with ICBC International and Caitong International as co-sponsors. As of the last practical date, the company's core product GBS has received regulatory approval in 11 other countries and regions, including Hong Kong, Indonesia, Thailand, Vietnam, Saudi Arabia, Malaysia, Ecuador, Colombia, the Philippines, Singapore and Brazil.